Depression Mental and Behavioural Disorders Depression
Conditions
Interventions
All able residents of all participating homes will be invited to participate in a brief baseline assessment lasting 15-20 minutes, measuring cognitive function, mobility, pain and quality of life. We
Sponsors
Department of Health (UK)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Assessment: 1. Permanent resident in residential or nursing home 2. Aged 65 or over 3. Consent/assent to assessment 4. Able to participate in baseline assessment Record check: 5. Consent/assent Exercise classes: 6. Able to transfer (with assistance from one person) from a wheelchair to a chair
Exclusion criteria
Exclusion criteria: Terminal or other serious illness
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Impact of the exercise intervention on depression levels measured through the use of the Geriatric Depression Scale (GDS) -15 at baseline and 12 months for all participants. For those who score highly on the GDS-15, we will also interview them at the 6-month stage in addition to the 2 timepoints for all residents. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Quality of life measured by EueroQoL 5 dimensions (EQ5D) at baseline and 12 months for all participants, and in addition at 6 months for those who score highly on the GDS-15. 2. Mobility measured by the Short Physical Performance Battery (SPPB) at baseline and 12 months for all participants, and in addition at 6 months for those who score highly on the GDS-15. 3. Injurious falls measured through home and hospital records. This will be collected at baseline, 3, 6, 9 and 12 months. 4. Cognitive function measured by the Mini Mental State Examination (MMSE) at baseline and 12 months for all participants, and in addition at 6 months for those who score highly on the GDS-15. 5. Pain, measured through participants' self reported level of pain on a five point scale at baseline and 12 months for all participants, and in addition at 6 months for those who score highly on the GDS-15. 6. Medication use, measured through their home records. This will be collected at baseline, 3, 6, 9 and 12 months. 7. Hospital Admissions. We will extract data on cause and duration of any hospital admissions during the study period from participants? hospital records. | — |
Countries
United Kingdom
Outcome results
None listed